2020
DOI: 10.1016/j.humimm.2020.08.007
|View full text |Cite
|
Sign up to set email alerts
|

TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…The presence of coding variation within the CDR3 of several novel alleles enabled the identification of these alleles in VDJdb, a curated database of published TCR CDR3s (43) TRB V and J usage was shown to be useful in guiding prognosis and immunotherapies in head and neck cancer cases, with dominant expression of specific V and J genes correlating with survival rates both in individuals with specific HLA allelic backgrounds and independent of HLA status (44). Intratumoral γδ T cells are the most favorable prognostic indicator in multiple cancers (45).…”
Section: Discussionmentioning
confidence: 99%
“…The presence of coding variation within the CDR3 of several novel alleles enabled the identification of these alleles in VDJdb, a curated database of published TCR CDR3s (43) TRB V and J usage was shown to be useful in guiding prognosis and immunotherapies in head and neck cancer cases, with dominant expression of specific V and J genes correlating with survival rates both in individuals with specific HLA allelic backgrounds and independent of HLA status (44). Intratumoral γδ T cells are the most favorable prognostic indicator in multiple cancers (45).…”
Section: Discussionmentioning
confidence: 99%
“…And, for particular autoimmune and infectious diseases, certain combinations of TCR gene segment usage and HLA alleles predominate (Miles et al., 2010; Miles et al., 2011; Quandt et al., 2012). Recently, this has been shown to be the case for certain cancer survival probability distinctions as well (Arndt et al., 2020; Callahan, Tong, et al., 2018; Callahan, Yavorski, et al., 2018; Cios et al., 2022; Clark et al., 2019; Huda et al., 2021; Roca et al., 2019; Tong et al., 2019). Presumably or possibly, the association of specific TCR gene segment usage, HLA allele combinations with cancer outcomes is due to certain combinations representing either a better or worse opportunity to present cancer antigens, reflecting analogous presumptions for autoimmunity and infectious diseases.…”
Section: Introductionmentioning
confidence: 94%